Its easy to blame menopause, but theres another shift affecting women in mid-life that often flies under the radar: a decline in human growth hormone (HGH)
You should never start a GLP-1 medication obtained without a prescription or without disclosing your full medication list to a licensed provider
Wegovy GLP-1 receptor agonist only Average weight loss of approximately 1315% in clinical trials In head-to-head comparison, semaglutide achieved 13.7% mean weight loss at 72 weeks Often better tolerated for some individuals Zepbound Dual GIP and GLP-1 receptor agonist Average weight loss of 1521% , depending on dose 5 mg: ~15% 10 mg: ~19.5% 15 mg: ~21% In head-to-head comparison, tirzepatide achieved 20.2% mean weight loss at 72 weeks This does not mean Zepbound is universally superior
Plans covering these agents consider coverage as: an investment into the health of their population
Amyloid PET scan and APOE determination Amyloid PET imaging was conducted using [11 C]PIB or [18 F]Flutemetamol tracers on Philips PET scanners (Gemini TF PET-CT, Ingenuity TF PET-CT, and Ingenuity PET/MRI
What is Semaglutide for weight loss